NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. (Q37089861)

https://api.crossref.org/works/10.1007%2FBF03256266

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV pharmacology: barriers to the eradication of HIV from the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV tat and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Early penetration of the blood-brain-barrier by HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Acute fulminating fatal leukoencephalopathy as the only manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

The AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Secondary mania in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Timed Gait test: normative data for the assessment of the AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neurologic signs and symptoms in a cohort of homosexual men followed for 4.5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Multivariate analysis of primitive reflexes in patients with human immunodeficiency virus type-1 infection and neurocognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuroimaging in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-1-associated central nervous system dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Monocyte/macrophage traffic in HIV and SIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Immune responses to HIV Gp120 that facilitate viral escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Structural basis for coreceptor selectivity by the HIV type 1 V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Mechanisms of the blood-brain barrier disruption in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuroimaging correlates of HIV-associated BBB compromise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV antigen in the brains of patients with the AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Mechanisms of neuronal injury and death in HIV-1 associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Evolving paradigms in the pathogenesis of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Gamma interferon primes productive human immunodeficiency virus infection in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Pathobiology of human immunodeficiency virus dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Identification of cis-regulatory regions necessary for robust Nos2 promoter activity in glial cells: indirect role for NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cell death in HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Extracellular HIV-1 Nef increases migration of monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF03256266

21 January 2018

12 December 2020

Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Elevated expression of IFN-gamma in the HIV-1 infected brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

An immune control model for viral replication in the CNS during presymptomatic HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: A case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid analysis for the diagnosis of human immunodeficiency virus-related neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrovascular changes in the basal ganglia with HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Compartmentalization and evolution of feline immunodeficiency virus between the central nervous system and periphery following intracerebroventricular or systemic inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid markers that predict SIV CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neopterin as a marker for immune system activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

A new HPLC method for serum neopterin measurement and relationships with plasma thiols levels in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CSF soluble Fas correlates with the severity of HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Regional distribution of lesions in the central nervous system of cats infected with feline immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Effects of wheatgerm agglutinin and aging on the regional brain uptake of HIV-1GP120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuropsychological differences but comparable regional cerebral blood changes in asymptomatic HIV-1-positive and -negative drug addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Impact of HIV on regional & cellular organisation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Lack of developmental neurotoxicity of MN rgp 120/HIV-1 administered subcutaneously to neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Short Communication: Unique HIV Type 1 V3 Region Sequences Derived from Six Different Regions of Brain: Region-Specific Evolution within Host-Determined Quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Acquired immunodeficiency syndrome and the risk of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

[An intracranial mass in a patient with HIV infection].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cranial polyneuropathy and brainstem disorder at the time of seroconversion in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Effects of methamphetamine dependence and HIV infection on cerebral morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Central nervous system pathology in children with AIDS. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cerebral lymphoma and HIV encephalitis in a case of paediatric AIDS, with Pre-Existing multicystic eneephalomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Regional decreases [corrected] in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neurobiology of simian and feline immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Human immunodeficiency virus-associated dementia: an evolving disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Influence of HAART on HIV-related CNS disease and neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neuro-immunity in stress-related oral ulcerations: a fractal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Bioinformatics models in drug abuse and Neuro-AIDS: Using and developing databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Gene chromosomal organization and expression in cultured human neurons exposed to cocaine and HIV-1 proteins gp120 and tat: drug abuse and NeuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Analytic approaches to differential gene expression in AIDS versus control brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

HIV-Producing T Cells in Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

High Plasma Levels of Soluble Fas in HIV Type 1-Infected Subjects Are Not Normalized during Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256266

Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependent mechanism

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF03256266

21 January 2018

12 December 2020

Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease

1 reference

12 December 2020

Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV.

1 reference

12 December 2020

Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy

1 reference

12 December 2020

Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

1 reference

12 December 2020

Neoplasms in the acquired immune deficiency syndrome: the multidisciplinary approach to treatment

1 reference

12 December 2020

Distribution of brain HIV load in AIDS.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy and gliomas in a HIV-negative patient

1 reference

12 December 2020

Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway

1 reference

12 December 2020

Clinical-neuropathologic correlation in HIV-associated dementia

1 reference

12 December 2020

The neuropathogenesis of HIV-1 infection

1 reference

12 December 2020

Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Astrocytic functions and physiological reactions to injury: the potential to induce and/or exacerbate neuronal dysfunction--a forum position paper

1 reference

12 December 2020

SPECT with 99mTc-HMPAO in subjects with HIV infection: cognitive dysfunction correlates with high uptake

1 reference

12 December 2020

Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.

1 reference

12 December 2020

Simian immunodeficiency virus (SIVsm) isolation from blood and brain of experimentally infected macaques

1 reference

12 December 2020

Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors

1 reference

12 December 2020

HIV penetration of the BBB

1 reference

12 December 2020

Constitutive nuclear factor-kappa B activity is required for central neuron survival.

1 reference

12 December 2020

Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero

1 reference

12 December 2020

The Edinburgh cohort of HIV-positive drug users: the relationship between auditory P3 latency, cognitive function and self-rated mood

1 reference

12 December 2020

CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel

1 reference

12 December 2020

Detection of HIV‐1 DNA in Microglia/ Macrophages, Astrocytes and Neurons Isolated from Brain Tissue with HIV‐1 Encephalitis by Laser Capture Microdissection

1 reference

12 December 2020

Evaluation of a new enzyme-linked immunosorbent assay for the determination of neopterin

1 reference

12 December 2020

Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment

1 reference

12 December 2020

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid

1 reference

12 December 2020

The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy

1 reference

12 December 2020

Utility of multiplex PCR for diagnosis of neurological disorders in HIV-infected patients and patients with AIDS

1 reference

12 December 2020

Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients

1 reference

12 December 2020

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest

1 reference

12 December 2020

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Motor skill impairment in SIV-infected rhesus macaques with rapidly and slowly progressing disease

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients

1 reference

12 December 2020

HIV Dementia Scale: a rapid screening test.

1 reference

12 December 2020

Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.

1 reference

12 December 2020

HIV proviral DNA associated with decreased neuropsychological function

1 reference

12 December 2020

Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

1 reference

12 December 2020

HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype

1 reference

12 December 2020

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

1 reference

12 December 2020

Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex

1 reference

12 December 2020

The neurological features of acute HIV infection

1 reference

12 December 2020

Evaluation of beta2 microglobulin level as a marker to determine HIV/AIDS progression

1 reference

12 December 2020

Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia

1 reference

12 December 2020

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

1 reference

12 December 2020

Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities.

1 reference

12 December 2020

[The mechanism of controlling regional cerebral blood flow in patients with localization-related epilepsy]

1 reference

12 December 2020

Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique

1 reference

12 December 2020

[Cognitive slowing in asymptomatic individuals who are seropositive for human immunodeficiency virus type 1]

1 reference

12 December 2020

Quantifying HIV-1 RNA Using the Polymerase Chain Reaction on Cerebrospinal Fluid and Serum of Seropositive Individuals With and Without Neurologic Abnormalities

1 reference

12 December 2020

Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brain

1 reference

12 December 2020

Cerebrospinal Fluid Mononuclear Cell Counts Influence CSF HIV-1 RNA Levels

1 reference

12 December 2020

HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era.

1 reference

12 December 2020

Pursuit eye movement dysfunction in HIV-1 seropositive individuals

1 reference

12 December 2020

Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus

1 reference

12 December 2020

[Principal clinical manifestations during the course of disease caused by the human immunodeficiency virus (HIV) in Pointe-Noire (Republic of Congo). (307 cases hospitalized during 2 years at the medical service of the Regional Hospital of the Army)

1 reference

12 December 2020

Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance

1 reference

12 December 2020

The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.

1 reference

12 December 2020

Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

1 reference

12 December 2020

Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120.

1 reference

12 December 2020

Recurrent transient neurological deficits in advanced HIV infection

1 reference

12 December 2020

Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study

1 reference

12 December 2020

Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study

1 reference

12 December 2020

The vpr Regulatory Gene of HIV

1 reference

12 December 2020

Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1

1 reference

12 December 2020

Early HIV-1 infection and the AIDS dementia complex

1 reference

12 December 2020

Gene expression in TUNEL-positive neurons in human immunodeficiency virus-infected brain

1 reference

12 December 2020

CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results

1 reference

12 December 2020